Those two patients presented ultra-rare variants in ACE2 gene, likely responsible for reduced viral load (Benetti et al. 2020b), and in AGTR2 gene, which reduced activity is known to prevent cystic fibrosis pulmonary manifestation (Darrah et al. 2019). The gene discussed is AGTR2; the disease is cystic fibrosis.